Ozempic-maker turns to Anthropic to turbocharge medical research

Key Points:

• Novo and AI company Anthropic have partnered to accelerate the development of new medicines and AI-driven healthcare software, aiming to make Novo the world’s most AI-driven healthcare company.
• Novo will utilize Anthropic’s AI models, including Claude Science, to enhance research and develop transformative solutions for chronic diseases, emphasizing AI’s potential to advance understanding of human biology and drug mechanics.
• Anthropic CEO Dario Amodei highlighted that frontier AI models could significantly shorten research timelines, potentially compressing a century of medical breakthroughs into a decade.
• The collaboration includes commitments to robust data governance and human oversight to ensure ethical use of AI technologies.
• European Commission President Ursula von der Leyen underscored the importance of AI in healthcare during her State of the EU speech, advocating for AI to support doctors, such as in early breast cancer detection, rather than replace them.